Joel Greenblatt's INVA Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 78,386 shares of Innoviva, Inc. (INVA) worth $1.78 M, representing 0.00% of the portfolio. First purchased in 2016-Q1, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in INVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2017, adding 489,223 shares. Largest reduction occurred in Q2 2018, reducing 92,367 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Innoviva (INVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Innoviva (INVA) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -43,413 | Reduce 35.64% | 78,386 | $22.71 |
| Q1 2026 | -7,719 | Reduce 5.96% | 121,799 | $23.30 |
| Q4 2025 | +16,772 | Add 14.88% | 129,518 | $19.99 |
| Q3 2025 | +28,340 | Add 33.58% | 112,746 | $18.25 |
| Q2 2025 | +19,244 | Add 29.53% | 84,406 | $20.09 |
| Q1 2025 | +21,263 | Add 48.44% | 65,162 | $18.13 |
| Q4 2024 | +11,912 | Add 37.24% | 43,899 | $17.35 |
| Q3 2024 | +1,519 | Add 4.99% | 31,987 | $19.31 |
| Q2 2024 | -4,496 | Reduce 12.86% | 30,468 | $16.40 |
| Q1 2024 | +10,370 | Add 42.16% | 34,964 | $15.24 |
| Q4 2023 | +6,393 | Add 35.12% | 24,594 | $16.04 |
| Q3 2023 | +2,181 | Add 13.61% | 18,201 | $12.99 |
| Q2 2023 | -10,724 | Reduce 40.10% | 16,020 | $12.73 |
| Q1 2023 | -13,140 | Reduce 32.95% | 26,744 | $11.25 |
| Q4 2022 | -2,292 | Reduce 5.43% | 39,884 | $13.25 |
| Q3 2022 | -18,163 | Reduce 30.10% | 42,176 | $11.62 |
| Q2 2022 | +9,618 | Add 18.96% | 60,339 | $14.77 |
| Q1 2022 | -4,689 | Reduce 8.46% | 50,721 | $19.34 |
| Q4 2021 | +17,021 | Add 44.34% | 55,410 | $17.25 |
| Q3 2021 | +2,975 | Add 8.40% | 38,389 | $16.70 |
| Q2 2021 | -5,309 | Reduce 13.04% | 35,414 | $13.41 |
| Q1 2021 | -43,219 | Reduce 51.49% | 40,723 | $11.96 |
| Q4 2020 | +3,814 | Add 4.76% | 83,942 | $12.39 |
| Q3 2020 | +22,621 | Add 39.34% | 80,128 | $10.45 |
| Q2 2020 | -37,763 | Reduce 39.64% | 57,507 | $13.98 |
| Q1 2020 | -11,664 | Reduce 10.91% | 95,270 | $11.76 |
| Q4 2019 | -54,142 | Reduce 33.61% | 106,934 | $14.16 |
| Q3 2019 | +3,181 | Add 2.01% | 161,076 | $10.54 |
| Q2 2019 | -70,332 | Reduce 30.82% | 157,895 | $14.56 |
| Q1 2019 | -65,026 | Reduce 22.17% | 228,227 | $14.03 |
| Q4 2018 | -85,209 | Reduce 22.51% | 293,253 | $17.45 |
| Q3 2018 | -74,040 | Reduce 16.36% | 378,462 | $15.24 |
| Q2 2018 | -92,367 | Reduce 16.95% | 452,502 | $13.80 |
| Q1 2018 | -7,886 | Reduce 1.43% | 544,869 | $16.67 |
| Q4 2017 | -36,312 | Reduce 6.16% | 552,755 | $14.19 |
| Q3 2017 | +17,844 | Add 3.12% | 589,067 | $14.12 |
| Q2 2017 | +489,223 | Add 596.61% | 571,223 | $12.80 |
| Q1 2017 | -3,288 | Reduce 3.86% | 82,000 | $13.83 |
| Q4 2016 | -9,104 | Reduce 9.64% | 85,288 | $10.70 |
| Q3 2016 | +28,001 | Add 42.18% | 94,392 | $10.99 |
| Q2 2016 | -2,876 | Reduce 4.15% | 66,391 | $10.53 |
| Q1 2016 | +69,267 | New Buy | 69,267 | $12.59 |
Joel Greenblatt's Innoviva Investment FAQs
Joel Greenblatt first purchased Innoviva, Inc. (INVA) in Q1 2016, acquiring 69,267 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Innoviva, Inc. (INVA) for 42 quarters since Q1 2016.
Joel Greenblatt's largest addition to Innoviva, Inc. (INVA) was in Q2 2017, adding 571,223 shares worth $7.31 M.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 78,386 shares of Innoviva, Inc. (INVA), valued at approximately $1.78 M.
As of the Q2 2026 filing, Innoviva, Inc. (INVA) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Innoviva, Inc. (INVA) was 589,067 shares, as reported at the end of Q3 2017.